GRDN: Vanguard reports 966,806-share position, slips under 5% ownership

Rhea-AI Filing Summary

On 06/30/2025 The Vanguard Group filed Amendment No. 1 to Schedule 13G covering Guardian Pharmacy Services Inc. (GRDN). Vanguard reports beneficial ownership of 966,806 common shares (CUSIP 40145W101), equal to 4.25 % of the outstanding stock. The investment adviser holds 0 shares with sole voting power and 16,335 shares with shared voting power; it retains 934,250 shares with sole dispositive power and 32,556 shares with shared dispositive power. Vanguard certifies the stake is held in the ordinary course of business with no intent to influence control. Item 5 notes that ownership is now below the 5 % reporting threshold.

Insights

Equity Analyst

TL;DR — Vanguard now owns 4.25 % of GRDN, signalling a passive position below the 5 % threshold; market impact likely limited.

The amended 13G shows Vanguard’s holding in Guardian Pharmacy Services falling under 5 %, a level that requires disclosure but removes “large shareholder” status. Voting power is minimal, confirming a purely passive stance. Because the filing lacks prior-period data, we cannot quantify the exact share reduction, yet the drop below 5 % can modestly trim perceived institutional sponsorship. Overall, no control intentions or strategic shifts are indicated, so valuation impact should be neutral.

Corporate Governance Specialist

TL;DR — Passive 4.25 % stake, no control intent; governance risk unchanged.

Vanguard’s certification under Rule 13d-1(b) and statement of ordinary-course ownership confirm that it is not seeking board influence. The lack of sole voting power suggests Vanguard delegates proxy decisions to underlying funds or third parties. From a governance perspective, the issuer’s control profile remains intact; there is no activist pressure or concerted group formation. Investors should view this as routine reporting compliance rather than a signal of strategic change.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Guardian Pharmacy Services Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

40145W101

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 40145W101

1

Names of Reporting Persons

The Vanguard Group

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 16,335.00
7	Sole Dispositive Power 934,250.00
8	Shared Dispositive Power 32,556.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

966,806.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.25 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Guardian Pharmacy Services Inc
(b)	Address of issuer's principal executive offices: 300 Galleria Parkway Southeast, Suite 800, Atlanta, GA, 30339
Item 2.
(a)	Name of person filing: The Vanguard Group
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd., Malvern, PA 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 40145W101
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 966806
(b)	Percent of class: 4.25 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 16335
	(iii) Sole power to dispose or to direct the disposition of: 934250
	(iv) Shared power to dispose or to direct the disposition of: 32556
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

The Vanguard Group

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	07/29/2025

FAQ

How many Guardian Pharmacy Services (GRDN) shares does Vanguard currently own?

Vanguard reports beneficial ownership of 966,806 common shares.

What percentage of GRDN’s outstanding stock does this represent?

The position equals 4.25 % of the outstanding common shares.

Does Vanguard intend to influence control of Guardian Pharmacy Services?

No. Vanguard certified the shares are held in the ordinary course with no intent to influence control.

What voting and dispositive powers did Vanguard disclose?

Vanguard has 0 sole voting power, 16,335 shared voting power, 934,250 sole dispositive power, and 32,556 shared dispositive power.

Why was this Schedule 13G/A filed on 06/30/2025?

Amendment No. 1 updates Vanguard’s holdings, which have fallen below the 5 % reporting threshold.